288 related articles for article (PubMed ID: 28131847)
1. Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole.
Beck KR; Bächler M; Vuorinen A; Wagner S; Akram M; Griesser U; Temml V; Klusonova P; Yamaguchi H; Schuster D; Odermatt A
Biochem Pharmacol; 2017 Apr; 130():93-103. PubMed ID: 28131847
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.
Beck KR; Telisman L; van Koppen CJ; Thompson GR; Odermatt A
J Steroid Biochem Mol Biol; 2020 May; 199():105605. PubMed ID: 31982514
[TBL] [Abstract][Full Text] [Related]
3. Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole.
Inderbinen SG; Zogg M; Kley M; Smieško M; Odermatt A
Toxicol Appl Pharmacol; 2021 Feb; 412():115387. PubMed ID: 33387577
[TBL] [Abstract][Full Text] [Related]
4. The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation.
Fürstenberger C; Vuorinen A; Da Cunha T; Kratschmar DV; Saugy M; Schuster D; Odermatt A
Toxicol Sci; 2012 Apr; 126(2):353-61. PubMed ID: 22273746
[TBL] [Abstract][Full Text] [Related]
5. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the study of 11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2)Inhibitors.
Zhou C; Ye F; Wu H; Ye H; Chen Q
Environ Toxicol Pharmacol; 2017 Jun; 52():47-53. PubMed ID: 28366868
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D
Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605
[TBL] [Abstract][Full Text] [Related]
9. In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity.
Kley M; Moser SO; Winter DV; Odermatt A
Methods Enzymol; 2023; 689():167-200. PubMed ID: 37802570
[TBL] [Abstract][Full Text] [Related]
10. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
[TBL] [Abstract][Full Text] [Related]
11. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
[TBL] [Abstract][Full Text] [Related]
12. Species-specific differences in the inhibition of human and zebrafish 11β-hydroxysteroid dehydrogenase 2 by thiram and organotins.
Meyer A; Strajhar P; Murer C; Da Cunha T; Odermatt A
Toxicology; 2012 Nov; 301(1-3):72-8. PubMed ID: 22796344
[TBL] [Abstract][Full Text] [Related]
13. Selection and optimization of MCF-7 cell line for screening selective inhibitors of 11beta-hydroxysteroid dehydrogenase 2.
Kim CH; Cho YS
Cell Biochem Funct; 2010 Aug; 28(6):440-7. PubMed ID: 20629036
[TBL] [Abstract][Full Text] [Related]
14. Direct inhibition of bisphenols on human and rat 11β-hydroxysteroid dehydrogenase 2: Structure-activity relationship and docking analysis.
Zhang B; Wang S; Tang Y; Hu Z; Shi L; Lu J; Li H; Wang Y; Zhu Y; Lin H; Ge RS
Ecotoxicol Environ Saf; 2023 Apr; 254():114715. PubMed ID: 36871355
[TBL] [Abstract][Full Text] [Related]
15. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ; Latif SA; Hardy MP; Brem AS
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
[TBL] [Abstract][Full Text] [Related]
17. The ERK1/2 signaling pathway regulates 11beta-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through a transcriptional mechanism.
Guan H; Sun K; Yang K
Biol Reprod; 2013 Oct; 89(4):92. PubMed ID: 23966319
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel 2-(Isopropylamino)thiazol-4(5
Kupczyk D; Studzińska R; Bilski R; Baumgart S; Kołodziejska R; Woźniak A
Molecules; 2020 Sep; 25(18):. PubMed ID: 32942682
[TBL] [Abstract][Full Text] [Related]
19. Species differences of 11beta-hydroxysteroid dehydrogenase type 2 function in human and rat term placenta determined via LC-MS/MS.
Heussner K; Ruebner M; Huebner H; Rascher W; Menendez-Castro C; Hartner A; Fahlbusch FB; Rauh M
Placenta; 2016 Jan; 37():79-84. PubMed ID: 26654513
[TBL] [Abstract][Full Text] [Related]
20. Direct inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by per- and polyfluoroalkyl substances: Structure-activity relationship and in silico docking analysis.
Zhao C; Wang S; Zhai Y; Wang M; Tang Y; Li H; Im YJ; Ge RS
Toxicology; 2023 Apr; 488():153484. PubMed ID: 36878351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
